Alps Advisors Inc. Buys Shares of 4,220 LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Alps Advisors Inc. bought a new position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 4,220 shares of the medical instruments supplier's stock, valued at approximately $354,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in LMAT. Raymond James Financial Inc. acquired a new position in shares of LeMaitre Vascular during the fourth quarter worth approximately $14,900,000. Rockefeller Capital Management L.P. acquired a new position in shares of LeMaitre Vascular during the fourth quarter worth approximately $7,787,000. Segall Bryant & Hamill LLC acquired a new position in shares of LeMaitre Vascular during the fourth quarter worth approximately $5,446,000. Invesco Ltd. lifted its holdings in shares of LeMaitre Vascular by 50.5% during the fourth quarter. Invesco Ltd. now owns 174,998 shares of the medical instruments supplier's stock worth $16,124,000 after buying an additional 58,720 shares during the last quarter. Finally, GAMMA Investing LLC lifted its holdings in shares of LeMaitre Vascular by 7,486.5% during the first quarter. GAMMA Investing LLC now owns 53,864 shares of the medical instruments supplier's stock worth $4,519,000 after buying an additional 53,154 shares during the last quarter. 84.64% of the stock is currently owned by institutional investors and hedge funds.

LeMaitre Vascular Stock Performance

Shares of LMAT stock traded down $2.33 during trading hours on Friday, reaching $79.77. 121,008 shares of the company's stock were exchanged, compared to its average volume of 169,186. LeMaitre Vascular, Inc. has a fifty-two week low of $71.42 and a fifty-two week high of $109.58. The stock has a market capitalization of $1.80 billion, a P/E ratio of 40.29, a P/E/G ratio of 2.10 and a beta of 0.82. The business has a fifty day moving average price of $82.82 and a 200-day moving average price of $87.74. The company has a quick ratio of 13.83, a current ratio of 16.49 and a debt-to-equity ratio of 0.48.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $0.48 EPS for the quarter, missing analysts' consensus estimates of $0.50 by ($0.02). The business had revenue of $59.87 million for the quarter, compared to analyst estimates of $57.61 million. LeMaitre Vascular had a return on equity of 13.53% and a net margin of 19.96%. The firm's quarterly revenue was up 12.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.44 earnings per share. Analysts predict that LeMaitre Vascular, Inc. will post 1.94 EPS for the current fiscal year.

LeMaitre Vascular Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th were given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 1.00%. The ex-dividend date was Thursday, May 15th. LeMaitre Vascular's dividend payout ratio (DPR) is 40.40%.

Insiders Place Their Bets

In other LeMaitre Vascular news, CEO George W. Lemaitre sold 4,399 shares of the business's stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $85.10, for a total value of $374,354.90. Following the transaction, the chief executive officer owned 1,827,003 shares of the company's stock, valued at approximately $155,477,955.30. The trade was a 0.24% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders sold 100,000 shares of company stock valued at $8,556,857 in the last quarter. Corporate insiders own 9.50% of the company's stock.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.